Deregulated expression of cell cycle-associated proteins in solid pseudopapillary tumor of the pancreas

Mod Pathol. 2001 Feb;14(2):47-53. doi: 10.1038/modpathol.3880255.

Abstract

Solid pseudopapillary tumor of the pancreas was studied in a 20-year-old woman and a 54-year-old woman. In the younger patient, the tumor had metastasized to the liver 8 years after distal pancreatectomy. In both neoplasms, the distinct histologic pattern of solid, pseudopapillary, and degenerative cystic areas was present. Analysis by means of immunohistochemistry revealed a diffuse expression for vimentin, neuron-specific enolase, and a focal positivity for al-antitrypsin, whereas epithelial markers were negative in the tumor of the older patient and only focally expressed in the tumor of the younger patient. Immunohistochemical analysis of cell cycle-associated proteins provided an overexpression of cyclin D1 and cyclin D3 in both tumors, although to varying degrees. In addition, the cyclin-dependent kinase inhibitors p21, and to a lesser extent p27, were up-regulated just as mdm2. There was no accumulation of p53 protein, and Ki67-positive cells were extremely scarce. Analysis of the liver metastases showed an immunoreactive profile similar to that of the primary tumor. The results show a deregulation of the cell cycle with overexpression of cell cycle-activating proteins D1 and D3 and a probably counterbalancing upregulation of the cyclin-dependent kinase inhibitors p21 and p27. The findings may explain the low pool of Ki67-reactive tumor cells and the generally good clinical outcome of these tumors. Whether a more profound dysbalance of the cell cycle regulation is responsible for the development of metastatic disease remains to be clarified.

Publication types

  • Case Reports

MeSH terms

  • Biomarkers, Tumor / metabolism
  • Carcinoma, Papillary / metabolism*
  • Carcinoma, Papillary / pathology
  • Carcinoma, Papillary / surgery
  • Child
  • Cyclin D1 / metabolism*
  • Cyclin D3
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclin-Dependent Kinases / antagonists & inhibitors
  • Cyclins / metabolism*
  • Enzyme Inhibitors / metabolism
  • Female
  • Humans
  • Microfilament Proteins / metabolism
  • Middle Aged
  • Muscle Proteins*
  • Pancreatic Neoplasms / metabolism*
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / surgery
  • Up-Regulation

Substances

  • Biomarkers, Tumor
  • CCND3 protein, human
  • CDKN1A protein, human
  • Ccnd3 protein, mouse
  • Cyclin D3
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Enzyme Inhibitors
  • Microfilament Proteins
  • Muscle Proteins
  • Tagln protein, mouse
  • Cyclin D1
  • Cyclin-Dependent Kinases